+3 | The top 3 med-tech stories for May 10, 2012.

May 10, 2012 by MassDevice staff

Riata's survival rates called "significantly worse" in an independent study, DePuy may be showing its hand in defending its recalled metal-on-metal hips ahead of court hearings and Covidien denies a widely disseminated rumor that it cut 200 workers to offset the cost of the medical device tax.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

3. Covidien denies layoffs tied to device tax

Contrary to a widely circulated statement, Covidien's decision to cut workers and shift production overseas was not motivated by the impending medical device tax, the company says.

Read more

Sign up to get our free newsletters delivered straight to your inbox

2. DePuy's BMJ fray: Is the hip maker showing its hand ahead of jury trials?

The contentious fracas between DePuy and a researcher over a study published in the British Medical Journal may be a preview of the company's arguments in court.